Two great aesthetic powers have merged.
Global pharmaceutical industry leader Allergan PLC has announced its intention to acquire Kythera Biopharmaceuticals, Inc., known for its aesthetically-focused products.
Allergan, the company responsible for fillers and injectables such as Botox, Juvéderm and Latisse, reportedly bought the company for $ 2.1 billion.
Recently Kythera made the news with the announcement of her new treatment, Kybella , which offers patients non-surgical treatment for submental fullness (double chin).
“As a leader in aesthetics, we know that our customers seek to offer their patients new options beyond traditional facial aesthetics.
Kybella will achieve this while complementing our industry-leading facial aesthetics portfolio, “said Brent Saunders, CEO and President of Allergan.